Education
About Us
Working with TipRanks
Follow Us
Genocea Biosciences (GNCAQ)
OTHER OTC:GNCAQ
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 1.64M | $ 1.36M | - | - | - |
| Operating Income | $ -52.10M | $ -46.99M | $ -38.99M | $ -39.52M | $ -52.64M |
| EBITDA | $ -30.01M | $ -40.74M | $ -36.91M | $ -25.70M | $ -53.75M |
| Net Income | $ -33.20M | $ -43.71M | $ -38.95M | $ -27.81M | $ -56.71M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 55.97M | $ 98.49M | $ 52.61M | $ 31.11M | $ 17.49M |
| Total Debt | $ 8.79M | $ 13.86M | $ 13.41M | $ 14.82M | $ 14.31M |
| Net Debt | $ -28.31M | $ -65.91M | $ -26.72M | $ -11.54M | $ 2.04M |
| Total Liabilities | $ 28.89M | $ 89.51M | $ 27.57M | $ 23.78M | $ 23.54M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -48.61M | $ -44.21M | $ -38.82M | $ -41.37M | $ -48.82M |
| Operating Cash Flow | $ -45.40M | $ -41.65M | $ -37.73M | $ -41.23M | $ -47.80M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Genocea Biosciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.